今天小一为大家整理了肿瘤学领域内,国人占比大于30%的期刊,一共87本。
|
期刊名称 |
影响因子 |
中科院分区 |
自引率 |
年发文量 |
国人发文 占比 |
0959-4973 |
ANTI-CANCER DRUGS |
1.8 |
4 |
0% |
142 |
76% |
0304-419X |
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER |
9.7 |
1 |
1% |
164 |
46% |
1471-2407 |
BMC CANCER |
3.4 |
2 |
2.90% |
1225 |
56% |
1075-122X |
Breast Journal |
1.9 |
4 |
0% |
22 |
36% |
1570-5870 |
CELLULAR ONCOLOGY |
4.9 |
2 |
2% |
139 |
75% |
1568-0096 |
CURRENT CANCER DRUG TARGETS |
2.3 |
4 |
0% |
70 |
51% |
1534-7354 |
INTEGRATIVE CANCER THERAPIES |
2.9 |
3 |
3.40% |
90 |
34% |
0393-6155 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS |
2.3 |
4 |
0% |
31 |
65% |
1871-5206 |
Anti-Cancer Agents in Medicinal Chemistry |
2.6 |
4 |
3.80% |
190 |
41% |
1574-0153 |
Cancer Biomarkers |
2.2 |
4 |
0% |
91 |
68% |
1475-2867 |
Cancer Cell International |
5.3 |
2 |
0% |
314 |
56% |
0340-7004 |
CANCER IMMUNOLOGY IMMUNOTHERAPY |
4.6 |
2 |
0% |
207 |
37% |
0304-3835 |
CANCER LETTERS |
9.1 |
1 |
6.60% |
280 |
71% |
0008-5472 |
CANCER RESEARCH |
12.5 |
1 |
0.80% |
284 |
34% |
0143-3334 |
CARCINOGENESIS |
3.3 |
3 |
0% |
86 |
70% |
0009-3157 |
CHEMOTHERAPY |
2 |
4 |
0% |
30 |
30% |
0392-2936 |
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY |
0.5 |
4 |
0% |
104 |
65% |
0171-5216 |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2.7 |
3 |
3.70% |
958 |
65% |
1120-009X |
JOURNAL OF CHEMOTHERAPY |
1.9 |
4 |
0% |
70 |
41% |
1756-8722 |
Journal of Hematology & Oncology |
29.5 |
1 |
1.70% |
70 |
61% |
1524-9557 |
JOURNAL OF IMMUNOTHERAPY |
3.2 |
4 |
0% |
44 |
39% |
1476-4598 |
Molecular Cancer |
27.7 |
1 |
2.20% |
165 |
61% |
0899-1987 |
MOLECULAR CARCINOGENESIS |
3 |
2 |
3.30% |
151 |
79% |
1791-2997 |
Molecular Medicine Reports |
3.4 |
3 |
0% |
178 |
70% |
1357-0560 |
MEDICAL ONCOLOGY |
2.8 |
4 |
0% |
323 |
35% |
1522-8002 |
NEOPLASIA |
6.3 |
2 |
1.60% |
79 |
32% |
0028-2685 |
NEOPLASMA |
2 |
4 |
0% |
74 |
72% |
0163-5581 |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2 |
4 |
0% |
112 |
44% |
0950-9232 |
ONCOGENE |
6.9 |
1 |
1.40% |
271 |
51% |
1292-3818 |
Oncologie |
1.4 |
4 |
7.10% |
78 |
78% |
0965-0407 |
ONCOLOGY RESEARCH |
2 |
4 |
0% |
71 |
70% |
1021-335X |
ONCOLOGY REPORTS |
3.8 |
3 |
2.60% |
162 |
59% |
1748-717X |
Radiation Oncology |
3.3 |
2 |
6.10% |
194 |
45% |
1574-8928 |
Recent Patents on Anti-Cancer Drug Discovery |
2.5 |
4 |
4% |
38 |
45% |
1533-0346 |
TECHNOLOGY IN CANCER RESEARCH & TREATMENT |
2.7 |
4 |
3.70% |
217 |
67% |
1936-5233 |
Translational Oncology |
4.5 |
2 |
2.20% |
233 |
70% |
2210-7177 |
Analytical Cellular Pathology |
2.6 |
4 |
0% |
42 |
88% |
1178-6930 |
OncoTargets and Therapy |
2.7 |
4 |
0% |
75 |
52% |
2210-7762 |
Cancer Genetics |
1.4 |
4 |
0% |
45 |
38% |
2211-3428 |
CELLULAR ONCOLOGY |
4.9 |
2 |
2% |
139 |
75% |
1936-2625 |
International Journal of Clinical and Experimental Pathology |
1.1 |
4 |
0% |
42 |
76% |
1073-2748 |
Cancer Control |
2.5 |
4 |
4% |
130 |
42% |
1944-7124 |
Translational Oncology |
4.5 |
2 |
2.20% |
233 |
70% |
2156-6976 |
American Journal of Cancer Research |
3.6 |
3 |
2.80% |
415 |
67% |
1943-8141 |
American Journal of Translational Research |
1.7 |
4 |
5.90% |
634 |
90% |
1349-7006 |
CANCER SCIENCE |
4.5 |
2 |
2.20% |
319 |
42% |
1750-9378 |
Infectious Agents and Cancer |
3.1 |
2 |
3.20% |
78 |
35% |
1837-9664 |
Journal of Cancer |
3.3 |
3 |
0% |
291 |
79% |
2212-1366 |
Journal of Bone Oncology |
3.1 |
2 |
3.20% |
49 |
55% |
2157-9024 |
Oncogenesis |
5.9 |
2 |
1.70% |
49 |
61% |
1792-1074 |
Oncology Letters |
2.5 |
4 |
0% |
511 |
64% |
2095-0217 |
Frontiers of Medicine |
3.9 |
3 |
2.60% |
77 |
95% |
2218-676X |
Translational Cancer Research |
1.5 |
4 |
6.70% |
261 |
91% |
1687-8450 |
Journal of Oncology |
0 |
3 |
0% |
31 |
87% |
2234-943X |
Frontiers in Oncology |
3.5 |
3 |
5.70% |
4479 |
59% |
1948-5204 |
World Journal of Gastrointestinal Oncology |
2.5 |
4 |
0% |
162 |
78% |
1868-7075 |
Clinical Epigenetics |
4.8 |
2 |
4.20% |
190 |
33% |
2305-5839 |
Annals of Translational Medicine |
0 |
4 |
0% |
72 |
86% |
2523-3548 |
Cancer Communications |
20.1 |
1 |
1.50% |
46 |
83% |
2050-7771 |
Biomarker Research |
9.5 |
2 |
1.10% |
84 |
67% |
2253-5969 |
Journal of Hepatocellular Carcinoma |
4.2 |
3 |
7.10% |
171 |
78% |
2078-6891 |
Journal of Gastrointestinal Oncology |
2 |
4 |
5% |
217 |
63% |
1179-5549 |
Clinical Medicine Insights-Oncology |
1.9 |
4 |
0% |
60 |
62% |
1179-1314 |
Breast Cancer-Targets and Therapy |
3.3 |
4 |
3% |
75 |
47% |
2095-3941 |
Cancer Biology & Medicine |
5.6 |
2 |
14.30% |
69 |
94% |
1538-4047 |
CANCER BIOLOGY & THERAPY |
4.4 |
4 |
0% |
81 |
75% |
1347-9032 |
CANCER SCIENCE |
4.5 |
2 |
2.20% |
319 |
42% |
0929-1903 |
CANCER GENE THERAPY |
4.8 |
3 |
2.10% |
124 |
56% |
1699-048X |
Clinical & Translational Oncology |
2.8 |
3 |
3.60% |
288 |
57% |
0265-6736 |
INTERNATIONAL JOURNAL OF HYPERTHERMIA |
3 |
3 |
13.30% |
137 |
64% |
1019-6439 |
INTERNATIONAL JOURNAL OF ONCOLOGY |
4.5 |
3 |
0% |
113 |
77% |
1756-9966 |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
11.4 |
1 |
1.80% |
280 |
58% |
1066-5099 |
STEM CELLS |
4 |
2 |
2.50% |
87 |
33% |
1759-7706 |
Thoracic Cancer |
2.3 |
3 |
4.30% |
376 |
53% |
1179-1322 |
Cancer Management and Research |
2.5 |
4 |
0% |
111 |
52% |
2001-1326 |
Clinical and Translational Medicine |
7.9 |
1 |
1.30% |
294 |
75% |
2162-3619 |
Experimental Hematology & Oncology |
9.4 |
1 |
6.40% |
71 |
72% |
2730-6011 |
Discover Oncology |
2.8 |
4 |
0% |
228 |
81% |
1000-9604 |
Chinese Journal of Cancer Research |
7 |
2 |
14.30% |
51 |
92% |
2212-1374 |
Journal of Bone Oncology |
3.1 |
2 |
3.20% |
49 |
55% |
2218-6751 |
Translational Lung Cancer Research |
4 |
2 |
5% |
166 |
46% |
0167-6997 |
INVESTIGATIONAL NEW DRUGS |
3 |
3 |
3.30% |
87 |
44% |
1470-7330 |
CANCER IMAGING |
3.5 |
2 |
2.90% |
122 |
52% |
1868-7083 |
Clinical Epigenetics |
4.8 |
2 |
4.20% |
190 |
33% |
2045-7634 |
Cancer Medicine |
2.9 |
2 |
3.40% |
1215 |
47% |
1219-4956 |
PATHOLOGY & ONCOLOGY RESEARCH |
2.3 |
4 |
0% |
94 |
56% |
1476-5586 |
NEOPLASIA |
6.3 |
2 |
1.60% |
79 |
32% |
但是各位宝子请注意,不是国人占比越高越好啊,有些被预警的就是因为国人占比畸高,看下面2024中科院预警期刊,大家一定要注意避开。
选刊学问大着呢,想了解更多的要持续关注小一哦~还想了解哪些医学其他领域的期刊情况,欢迎联系一研学术
相关文章推荐